The down-modulation of the PD-1 pathway is not because of inherent defective signaling in RA, since exogenous PD-L1-Fc was able to transduce its inhibitory signal in CD3-activated CD4+ T memory cells from RA patients, leading to decreased cell proliferation (Fig 3C). The gene discussed is CD274; the disease is rheumatoid arthritis.